Amanote Research
Register
Sign In
Neovascular Age-Related Macular Degeneration and Chlamydia Pneumoniae Antibodies in Asian Patients: A Pilot Case-Control Study
Indian Journal of Inflammation Research
doi 10.15305/ijir/v2i1/282
Full Text
Open PDF
Abstract
Available in
full text
Date
September 30, 2018
Authors
Sanjay S.
Jureen SR
Joseph A. M.
Omar A.
Publisher
ChanRe Healthcare and Research
Related search
Macular Atrophy in Neovascular Age Related Macular Degeneration
Journal of Clinical Review & Case Reports
Effect of Mitochondrial Haplogroups on Ranibizumab Response in Neovascular Age-Related Macular Degeneration Patients: A Pilot Study
Acta Ophthalmologica
Medicine
Ophthalmology
Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Aflibercept for Neovascular Age-Related Macular Degeneration
Cochrane Database of Systematic Reviews
Pss62 - Treatment Preference Drivers of Patients With Neovascular Age-Related Macular Degeneration
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ranibizumab Versus Verteporfin for Neovascular Age-Related Macular Degeneration
New England Journal of Medicine
Medicine
Macular Functional Changes in Patients With Neovascular Age-Related Macular Degeneration Receiving Ranibizumab Therapy (Lucentis)
BMC Geriatrics
Gerontology
Geriatrics
Development and Testing of a Patient-Derived Questionnaire for Treatment of Neovascular Age-Related Macular Degeneration: Dimensions of Importance in Treatment of Neovascular Age-Related Macular Degeneration
Acta Ophthalmologica
Medicine
Ophthalmology
Role of Interleukin 33 in Neovascular Age-Related Macular Degeneration
The Lancet
Medicine
